Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cord blood transplant study aims to improve survival for blood cancer patients

NCT ID NCT06712108

First seen Feb 02, 2026 · Last updated Jun 18, 2026 · Updated 20 times

Summary

This study is observing how safe and effective a double umbilical cord blood transplant is for Korean adults with blood cancers like leukemia and lymphoma. About 40 participants will receive either a mild or strong pre-transplant treatment, then the transplant. Researchers will track survival, engraftment, and side effects like graft-versus-host disease to learn more about this approach.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Dong-A University Hospital

    NOT_YET_RECRUITING

    Pusan, South Korea

    Contact

    Contact

    Contact

  • Jeonbuk National University Hopital

    NOT_YET_RECRUITING

    Jeonju, Jeonlabuk-do, South Korea

    Contact

    Contact

    Contact

  • Keimyung Unversity Dongsan Hospital

    NOT_YET_RECRUITING

    Daegu, South Korea

    Contact

    Contact

  • Pusan National University Hospital

    NOT_YET_RECRUITING

    Pusan, South Korea

    Contact

    Contact

    Contact

  • Seoul National University Bundang Hospital

    NOT_YET_RECRUITING

    Seongnam, South Korea

    Contact

    Contact

    Contact

  • Seoul National University Hospital

    RECRUITING

    Seoul, South Korea

    Contact

    Contact

    Contact

    Contact

    Contact

    Contact

Conditions

The condition(s) this trial relates to.

acute leukemia aplastic anemia chronic leukemia lymphosarcoma myelodysplastic syndrome myeloproliferative neoplasm plasma cell myeloma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.